REPUBLIC HC plans to invest in Langgu Bio through capital increase and share expansion
I'm PortAI, I can summarize articles.
REPUBLIC HC announced that it has signed a letter of intent for an investment agreement with Langgu Bio, planning to invest through capital increase and share expansion. The investment amount and shareholding ratio will be determined in the formal agreement. Langgu Bio's personalized DC vaccine technology has been approved for clinical treatment, marking its transformation into a profitable enterprise. This move will help REPUBLIC HC expand into the Southeast Asian and Greater China markets, enhance investment returns, and create new business opportunities
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments